BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16326019)

  • 21. Rnd family genes are differentially regulated by 3,4-methylenedioxymethamphetamine and cocaine acute treatment in mice brain.
    Marie-Claire C; Salzmann J; David A; Courtin C; Canestrelli C; Noble F
    Brain Res; 2007 Feb; 1134(1):12-7. PubMed ID: 17196187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
    Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
    Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of D1- and D2-like compounds on cocaine self-administration in Lewis and Fischer 344 inbred rats.
    Haile CN; Kosten TA
    J Pharmacol Exp Ther; 2001 Nov; 299(2):509-18. PubMed ID: 11602661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.
    Betancur C; Lépée-Lorgeoux I; Cazillis M; Accili D; Fuchs S; Rostène W
    Neuropsychopharmacology; 2001 Feb; 24(2):170-82. PubMed ID: 11120399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nicotine and cocaine on neurofilaments and receptors in whole brain tissue and synaptoneurosome preparations.
    Kovacs K; Lajtha A; Sershen H
    Brain Res Bull; 2010 Apr; 82(1-2):109-17. PubMed ID: 20188799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors.
    Zhang D; Zhang L; Tang Y; Zhang Q; Lou D; Sharp FR; Zhang J; Xu M
    Neuropsychopharmacology; 2005 Aug; 30(8):1443-54. PubMed ID: 15770241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cocaine on c-fos and NGFI-B mRNA expression in transgenic mice underexpressing glucocorticoid receptors.
    St-Hilaire M; Tremblay PO; Lévesque D; Barden N; Rouillard C
    Neuropsychopharmacology; 2003 Mar; 28(3):478-89. PubMed ID: 12629527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment.
    Ghasemzadeh MB; Nelson LC; Lu XY; Kalivas PW
    J Neurochem; 1999 Jan; 72(1):157-65. PubMed ID: 9886066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid receptors in dopaminoceptive neurons, key for cocaine, are dispensable for molecular and behavioral morphine responses.
    Barik J; Parnaudeau S; Saint Amaux AL; Guiard BP; Golib Dzib JF; Bocquet O; Bailly A; Benecke A; Tronche F
    Biol Psychiatry; 2010 Aug; 68(3):231-9. PubMed ID: 20554270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum.
    Drago J; Gerfen CR; Westphal H; Steiner H
    Neuroscience; 1996 Oct; 74(3):813-23. PubMed ID: 8884777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cocaine-induced dendritic remodeling occurs in both D1 and D2 dopamine receptor-expressing neurons in the nucleus accumbens.
    Li J; Liu N; Lu K; Zhang L; Gu J; Guo F; An S; Zhang L; Zhang L
    Neurosci Lett; 2012 May; 517(2):118-22. PubMed ID: 22561554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility to the long-term anxiogenic effects of an acute stressor is mediated by the activation of the glucocorticoid receptors.
    Jakovcevski M; Schachner M; Morellini F
    Neuropharmacology; 2011 Dec; 61(8):1297-305. PubMed ID: 21820452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated cocaine administration differentially affects NMDA receptor subunit (NR1, NR2A-C) mRNAs in rat brain.
    Yamaguchi M; Suzuki T; Abe S; Hori T; Kurita H; Asada T; Okado N; Arai H
    Synapse; 2002 Dec; 46(3):157-69. PubMed ID: 12325043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-transcriptional regulation of dopamine D1 receptor expression in caudate-putamen of cocaine-sensitized mice.
    Tobón KE; Catuzzi JE; Cote SR; Sonaike A; Kuzhikandathil EV
    Eur J Neurosci; 2015 Jul; 42(2):1849-57. PubMed ID: 25900179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma-hydroxybutyrate and cocaine administration increases mRNA expression of dopamine D1 and D2 receptors in rat brain.
    Schmidt-Mutter C; Muller C; Zwiller J; Gobaille S; Maitre M
    Neuropsychopharmacology; 1999 Nov; 21(5):662-9. PubMed ID: 10516962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive changes in the proenkephalin and D2 dopamine receptor mRNA expression after chronic cocaine in the nucleus accumbens and striatum of the rat.
    Przewłocka B; Lasoń W
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):465-9. PubMed ID: 8998398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors.
    Qin ZH; Zhou LW; Weiss B
    Neuroscience; 1994 May; 60(1):97-114. PubMed ID: 8052421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors.
    Schroeder FA; Penta KL; Matevossian A; Jones SR; Konradi C; Tapper AR; Akbarian S
    Neuropsychopharmacology; 2008 Nov; 33(12):2981-92. PubMed ID: 18288092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Fos is an intracellular regulator of cocaine-induced long-term changes.
    Xu M
    Ann N Y Acad Sci; 2008 Oct; 1139():1-9. PubMed ID: 18991842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampus.
    Blanco E; Galeano P; Palomino A; Pavón FJ; Rivera P; Serrano A; Alen F; Rubio L; Vargas A; Castilla-Ortega E; Decara J; Bilbao A; de Fonseca FR; Suárez J
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):477-92. PubMed ID: 26811312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.